Foster City or United States or Thousand Oaks or El Segundo or Parsippany or Santa Monica
$238k-$338k/yrHybridFull Time
Kite PharmaNASDAQ: GILD: Developing engineered cell therapies to treat and cure cancer.
12+ YOERequires 12+ years with an MS/PhD or 14+ years with a BA/BS; preferred progressive biostatistics industry experience, regulatory strategy, therapeutic-area expertise, and people leadership.
CytokineticsNASDAQ: CYTK: Develops muscle-directed medicines for cardiovascular and neuromuscular diseases.
8+ YOEPh.D. or M.S. in Statistics/Biostatistics with extensive biotech/pharma experience (8+ years for PhD, 12+ for MS). Hands-on clinical trial design/analysis, R proficiency, ML experience, and knowledge of ICH/regulatory guidance.
ExelixisNASDAQ: EXEL: Discovers and commercializes innovative medicines for cancer treatment.
12+ YOELeadership of biostatistics for early-phase oncology trials; MS/PhD in Statistics/Biostatistics with extensive experience (12+ years); experience with clinical biomarkers, omics, CDISC, FDA/EMA/ICH guidelines, managing statisticians, and vendor oversight.
Uniquity Bio: Develops novel therapeutics for immune-mediated diseases.
12+ YOEPhD or MS in biostatistics/statistics or related field, typically 12+ years industry biostatistics experience with leadership, experience across clinical phases and regulatory submissions, strong SAP/protocol authorship, and hands-on R and/or SAS experience.
Bristol Myers SquibbNew York Stock Exchange: BMY: Develops and distributes innovative medicines for serious diseases.
3+ YOEPhD+3yrs or MS+5yrs in statistics/biostatistics, proficiency in SAS,R,Python, experience with clinical trials, regulatory knowledge, strong communication and leadership skills.
3+ YOEPhD (3+ years) or MS (5+ years) in statistics/biostatistics, clinical trials experience, proficiency with SAS,R,Python, strong communication and regulatory understanding.
Nektar TherapeuticsNASDAQ: NKTR: Develops polymer-based medicines for autoimmune and inflammatory diseases.
12+ YOE6+ MgmtPhD or MS in Biostatistics (PhD preferred); 12+ years (PhD) or 15+ years (MS) experience; 6+ years people management; expert SAS; experience with adaptive trial design and regulatory submissions (FDA/ICH).
California University of Science and Medicine: Private medical school providing health sciences education and research.
2+ YOEDoctorate in biostatistics/epidemiology or related required with minimum 2 years relevant experience; expertise in advanced statistical methods, data management, teaching, and scholarly activity.
Revolution MedicinesNASDAQ: RVMD: Developing precision oncology therapies for RAS-addicted cancers
8+ YOEPh.D. or M.S. in Statistics/Biostatistics plus 8 years' experience with a Ph.D. or 12 years with an M.S.; oncology trial design and analysis, SAS or R, communication, and project management skills required.
Rapport TherapeuticsNASDAQ: RAPP: Developing precision medicines for neurological and psychiatric disorders.
3+ YOEPhD with 3+ or MS with 6+ years for Senior Manager; PhD with 6+ or MS with 9+ years for Associate Director. Requires biostatistics, clinical trial, SAS or R, CDISC, and regulatory expertise.
Sakata Seed AmericaTokyo Stock Exchange: 1377: Breeding and distributing high-quality vegetable and flower seeds.
0+ YOEPhD or MS in relevant quantitative field preferred; foundational training in statistics/quantitative genetics; experience with genomic/phenotypic/field-trial data and statistical programming (R, Python, SAS).
15+ YOEDoctorate in statistics/biostatistics/mathematics, 15+ years pharma/biotech experience with senior leadership, deep GCP/regulatory knowledge, advanced analytics/AI interest, international travel ~20%, relocation assistance offered.
IDEAYA BiosciencesNASDAQ: IDYA: Develops precision medicine oncology therapies for cancer patients.
15+ YOEPh.D. or M.S. in Statistics,15+ years statistical drug development experience with 10+ years in oncology and 8+ years supporting drug safety/pharmacovigilance; experience with NDA/BLA submissions and leadership in biostatistics.
Kardigan: Developing precision medicines to treat and cure cardiovascular disease.
15+ YOEPhD in biostatistics/statistics,15+ years late‑phase pharma/biotech experience, NDA/BLA signatory experience, direct FDA interaction, expertise in late‑phase methodology and Bayesian approaches, leadership and regulatory strategy.
Fate TherapeuticsNASDAQ: FATE: Develops cellular immunotherapies for cancer and autoimmune diseases.
4+ YOEPhD in statistics (or MS with additional experience), 4+ years industry experience (PhD+4 or MS+7), strong statistical methods knowledge, GCP/ICH/CDISC familiarity, SAS programming, communication and project management skills.
2+ YOELead statistical execution for clinical programs, manage external statisticians/programmers, evaluate CDISC packages, proficiency in SAS and R, MS/PhD preferred, and minimum 2 years clinical trial experience.
NateraNASDAQ: NTRA: Provides clinical genetic testing and diagnostics services.
8+ YOE5+ Mgmt8+ years industry experience (5+ in diagnostics), 5+ years leading teams, Master’s in statistics/biostatistics required (PhD preferred), experience with NGS/genetics/oncology and regulatory interactions (FDA, CAP/CLIA).